Diabetes management: Improving sensor performance
The burden of diabetes
An estimated 371 million people worldwide are living with diabetes; it’s fast becoming an epidemic. We are helping fight diabetes because of its profound effect on kidney failure, blindness, heart disease and stroke — as well as the overall quality of life. We’re helping medical device manufacturers provide patient solutions that minimize or prevent these complications by keeping glucose levels within a healthy, manageable range.
Advances in diabetes management
Continuous glucose monitoring is helping hundreds of thousands of patients improve glucose control. Tiny sensors inserted under the skin monitor glucose continuously and alert the patient when glucose levels are out of normal range. Patients can then take steps to correct any imbalance. DSM scientists have developed materials which help to improve the performance of these biosensors by assisting in reducing fouling and optimizing glucose exposure.
Polyurethanes improve accuracy
DSM medical polyurethanes optimize glucose diffusion, reducing the likelihood of sensor overload from glucose overexposure. With flexible mechanical properties and our patented Surface Modifying End Groups (SME®) and Self-Assembly Monolayer End Group (SAME®) surface technologies, our materials can be processed via multiple production techniques. This powerful combination of properties enables sensors to more accurately measure glucose levels and minimize patient discomfort. Furthermore, they’re proven for short- or long-term use.
- Capillary tubes
- Components of a continuous glucose monitoring system
- Biosensors, both in vivo and in vitro
- Disposable glucose strips
- Insulin pens and insulin pumps
- Microfluidic cartridges
- Point-of-care biosensors
- Prefilled syringes and cartridges